Marvell Technology(MRVL)
Search documents
Marvell (MRVL) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates
ZACKS· 2025-05-23 14:21
Core Viewpoint - Marvell Technology (MRVL) is expected to report significant year-over-year growth in both earnings and revenues in its upcoming quarterly report, with earnings per share projected at $0.61 and revenues at $1.88 billion, reflecting increases of 154.2% and 61.6% respectively [1] Revenue Estimates by End Market - Analysts predict that 'Net Revenue by end market- Data center' will reach $1.43 billion, indicating a year-over-year change of +74.8% [4] - The 'Net Revenue by end market- Carrier infrastructure' is estimated to be $116.43 million, showing a year-over-year increase of +62.2% [4] - For 'Net Revenue by end market- Automotive/industrial', the average prediction is $79.83 million, suggesting a change of +2.9% year over year [4] - The 'Net Revenue by end market- Consumer' is expected to arrive at $65.70 million, reflecting a year-over-year change of +56.4% [5] - Analysts estimate 'Net Revenue by end market- Enterprise networking' to reach $187.55 million, indicating a change of +22.5% from the year-ago quarter [5] Stock Performance - Marvell shares have experienced a +7.9% change in the past month, compared to the Zacks S&P 500 composite's +10.7% move, suggesting that MRVL is expected to closely follow overall market performance in the near term [6]
Jim Cramer: Rivian Better Than This Automaker, Pan American Silver Is The 'Best Silver Mine'
Benzinga· 2025-05-22 12:18
Group 1: Company Performance and Comparisons - Rivian Automotive, Inc. (RIVN) is viewed more favorably than Lucid Group, Inc. (LCID), with Lucid reporting first-quarter revenue of $235.05 million, missing analyst estimates of $250 million [1] - Marvell Technology, Inc. (MRVL) is considered a good buy, especially after announcing a collaboration with Nvidia Corp (NVDA) to offer NVLink Fusion technology [2] - Pony AI Inc. (PONY) reported first-quarter sales growth of 11.6% year-over-year to $13.98 million, exceeding analyst consensus estimates of 90.11 million Chinese yuan [2] Group 2: Mergers and Acquisitions - Pan American Silver Corp. (PAAS) is recognized as the best silver mine, and it has announced a definitive deal to acquire MAG Silver Corp. (MAG) shares [3] Group 3: Earnings Guidance and Market Sentiment - Doximity, Inc. (DOCS) provided a fiscal first-quarter revenue guidance of $139 million to $140 million, below estimates of $143.34 million, leading to a negative outlook [3] - Micron Technology, Inc. (MU) is perceived as having a "toppy" market position, with analysts expecting quarterly earnings of $1.59 per share on revenue of $8.83 billion [4] Group 4: Stock Price Movements - Lucid shares fell 6.4% to $2.77, Marvell shares declined 2.1% to $60.11, Pony.ai shares dropped 3.3% to $17.29, Doximity shares decreased 4.3% to $50.75, and Micron shares slipped 2.3% to $95.84 [7] - Pan American Silver shares rose 1.3% to $24.10 [7]
IP 设计服务展望:2026 年 ASIC 市场动态
2025-05-22 05:50
Summary of Conference Call Notes Industry Overview - The conference call focuses on the ASIC (Application-Specific Integrated Circuit) market dynamics, particularly involving major players like AWS, Google, Microsoft, and META, with projections extending into 2026 and beyond [1][2][5]. Key Company Insights AWS - AWS has resolved issues with Trainium 3 and continues to secure orders from downstream suppliers. The development of Trainium 4 has commenced, with expectations for a contract signing soon [2][5]. - The specifications for AWS's TPU chips are significantly higher than competitors, with TPU v6p and TPU v7p expected to have ASPs of US$8,000 and higher, respectively [2]. Google - Google is progressing steadily with its TPU series, with TPU v6p featuring advanced specifications including multiple compute and I/O dies. The company is anticipated to become a top customer for GUC due to its rapid ramp-up in CPU development [2][10]. - The revenue from Google's 3nm server CPU is expected to contribute to GUC's revenue sooner than previously anticipated, moving from Q4 2025 to Q3 2025 [10]. Microsoft - Microsoft is working on its Maia v2 ASIC, with a target of ramping 500,000 chips in 2026. However, the project has faced delays, pushing the tape-out timeline from Q1 2025 to Q2 2025 [3][4]. - The allocation of chips has shifted, with expectations of 40-60k chips for MSFT/GUC and 400k chips for Marvell in 2026 [3]. META - META is transitioning from MTIA v2 to MTIA v3, with expectations of ramping 100-200k chips for MTIA v2 and 200-300k chips for MTIA v3 in 2026 [2]. Non-CSPs - Companies like Apple, OpenAI, and xAI are entering the ASIC server market, with many expected to tape out in 2H25 and ramp in 2H26. These companies are likely to collaborate with Broadcom for high-end ASIC specifications [7][8][9]. Financial Projections - GUC's FY25 revenue is expected to exceed previous forecasts, driven by contributions from Google and crypto projects. However, concerns remain about FY26 growth without crypto revenue, with a projected 50% YoY growth in MP revenue [10][11]. - The revenue contribution from various ASIC projects in 2026 includes significant figures such as US$16,756 million from TPU v6p and US$2,616 million from Trainium 3 [18]. Additional Insights - The competitive landscape for ASIC design services is intensifying, with Broadcom and MediaTek entering the fray alongside existing players like Marvell and GUC [4][15]. - The potential impact of geopolitical factors on HBM2E clients was discussed, highlighting the resilience of Faraday in the face of possible restrictions [14]. Conclusion - The ASIC market is poised for significant growth, driven by advancements in technology and increasing demand from both CSPs and non-CSPs. Key players are adapting their strategies to navigate challenges and capitalize on emerging opportunities in the sector [1][5][7].
Marvell Technology: Potentially A Top AI Opportunity
Seeking Alpha· 2025-05-22 05:22
Marvell Technology (NASDAQ: MRVL ) is down over 40% year to date, and I think it could be an incredible opportunity for tech, AI, or growth investors. The stock is down nearly 50% from its all-time highs set at the start of this year, andMy name is Jake Blumenthal, I serve as a Wealth Management Advisor & Portfolio Analyst at Meridian Wealth Management, a registered investment advisory. I use a combination of financial, technical, and macroeconomic analysis to best support my clients, form my opinions, and ...
Marvell and NVIDIA to Provide Custom Solutions for Advanced AI Infrastructure
Prnewswire· 2025-05-19 06:05
Core Insights - Marvell Technology is collaborating with NVIDIA to integrate NVIDIA NVLink Fusion technology with Marvell's custom cloud platform silicon, enhancing flexibility for AI infrastructure development [1][5] - The partnership aims to provide hyperscalers with accelerated custom scale-up solutions for AI model training and inference, leveraging existing architecture investments in NVLink [3][4] Company Strategy - Marvell's custom platform strategy focuses on delivering innovative semiconductor designs and solutions, including advanced packaging, silicon photonics, and high-bandwidth memory, to improve infrastructure performance and efficiency [2] - The collaboration with NVIDIA allows Marvell to offer scalable AI infrastructure that meets the demands of advanced AI models, emphasizing the importance of bandwidth, performance, and reliability [5] Technology Integration - NVLink Fusion technology enables cloud providers to scale AI capabilities by integrating proprietary XPUs into NVIDIA's rack-scale systems, achieving up to 1.8TB/s of bidirectional bandwidth [4] - The integration of custom silicon with NVIDIA's end-to-end networking platform is positioned as a key enabler for hyperscalers to expand their AI factories [5]
英伟达CEO黄仁勋:正与Marvell、联发科合作开发专用晶片,并与高通合作开发CPU。
news flash· 2025-05-19 04:04
英伟达CEO黄仁勋:正与Marvell、联发科合作开发专用晶片,并与高通合作开发CPU。 ...
贝莱德Q1持仓:仍偏爱科技巨头 重仓苹果、微软、英伟达
news flash· 2025-05-16 08:51
贝莱德Q1持仓:仍偏爱科技巨头 重仓苹果、微软、英伟达 金十数据5月16日讯,贝莱德13F报告显示,一季度持仓总市值为4.76万亿美元,环比下降3.6%。前十大 重仓股中,大型科技公司仍占多数。苹果仍位列第一,持仓占比为5.32%。其次是微软、英伟达、亚马 逊和Meta。从持仓比例变化来看,前五大买入标的为SPDR标普500ET、伯克希尔哈撒韦-B、Visa、艾 伯维、礼来。前五大卖出标的包括迈威尔科技、Adobe、The Trade Desk、Deckers Outdoor、伊顿。 订阅13F持仓变动 +订阅 ...
Marvell Vs Micron Technology: Which AI Chip Stock is the Better Investment
ZACKS· 2025-05-15 22:21
Core Viewpoint - Market sentiment has turned bullish as global trade fears subside, leading investors to focus on AI chip providers like Marvell Technology and Micron Technology [1] Company Overview - Marvell specializes in custom networking chips for AI infrastructure, while Micron focuses on memory and storage solutions, including high-bandwidth memory and advanced DRAM [2] Performance Overview - Marvell's stock has increased by 12% this month, while Micron's shares have surged over 20%. However, Marvell's stock is down 40% in 2025 due to weaker guidance and postponed events, whereas Micron's shares are up 12% year-to-date driven by strong AI memory demand [3] - Over the past five years, Marvell's stock has risen over 130%, while Micron's has increased by 106%, both outperforming the Nasdaq and slightly exceeding the S&P 500 [4] Growth Projections - Marvell's total sales are expected to rise by 43% in fiscal 2025 to $8.28 billion, with further growth projected at 18% to $9.78 billion in FY26. Earnings per share (EPS) are forecasted to increase by 75% to $2.75 in FY25 and by 27% to $3.50 in FY26 [5] - Micron's sales are projected to grow by 41% to $35.49 billion in FY25 and by 30% to $46.11 billion in FY26. EPS is expected to rebound to $6.93 from $1.30 last year, with a further increase of 56% to $10.79 in FY26 [7] Valuation Comparison - Marvell's stock is trading at 23.9X forward earnings, near the S&P 500 average and offering a 47% discount to its decade-long median of 45.5X. Micron shares are trading at a 13.7X forward earnings multiple, close to its decade-long median of 11.4X [10] Investment Consideration - Both Marvell and Micron are considered intriguing chip stocks, currently holding a Zacks Rank 3 (Hold). Analysts are more bullish on Micron due to demand for its memory solutions, while Marvell's custom networking chips are also critical for technological advancements [12][13]
金十图示:2025年05月13日(周二)全球主要科技与互联网公司市值变化





news flash· 2025-05-13 02:59
Market Capitalization Changes - Tesla's market capitalization increased by 6.75% to $1,025.4 billion [3] - TSMC's market capitalization rose by 5.93% to $969.7 billion [3] - Tencent's market capitalization grew by 4.66% to $609.8 billion [3] - Netflix's market capitalization decreased by 2.65% to $472.3 billion [3] - Oracle's market capitalization increased by 4.58% to $440.8 billion [3] Notable Performers - Shopify saw a significant increase of 13.7% in market capitalization, reaching $136.2 billion [4] - AppLovin experienced a remarkable rise of 89% to $1.177 billion [4] - AMD's market capitalization increased by 5.13% to $175.3 billion [5] - Uber's market capitalization rose by 6.39% to $184.2 billion [5] Decliners - Pinduoduo's market capitalization fell by 6.14% to $165.2 billion [4] - Xiaomi's market capitalization decreased by 2.11% to $163.4 billion [4] - Spotify's market capitalization declined by 4.23% to $127.3 billion [4] Other Companies of Interest - Adobe's market capitalization increased by 3.3% to $168.7 billion [4] - Qualcomm's market capitalization rose by 4.78% to $167.0 billion [4] - Intel's market capitalization increased by 3.55% to $96.7 billion [5] - Airbnb's market capitalization grew by 5.64% to $828 million [5]
Marvel Biosciences Announces Closing of Private Placement
Newsfile· 2025-05-12 22:05
Group 1 - Marvel Biosciences Corp. has closed a non-brokered private placement, issuing 8,150,000 units at a price of $0.125 per unit, resulting in gross proceeds of $1,018,750 [1][2] - Each unit consists of one common share and one common share purchase warrant, with the warrant allowing the purchase of one common share at an exercise price of $0.175 per share for two years [2] - The company is developing MB-204, a novel fluorinated derivative of the anti-Parkinson's drug Istradefylline, which may also be effective in treating other neurological diseases such as autism, depression, and Alzheimer's Disease [3] Group 2 - The company is actively investigating the potential of MB-204 in addressing neurodevelopmental disorders like Rett Syndrome and Fragile X Syndrome to expand its therapeutic applications [3]